Skip Ribbon Commands
Skip to main content

​​​​The Collaboration for TB Vaccine Discovery (CTVD) is an international network of scientists and experts dedicated to fostering innovation, cooperation, and collaboration in the up-stream TB vaccine discovery space.
​

Tuberculosis (TB) is an infectious disease caused by the bacillus Mycobacterium tuberculosis. While effective diagnosis and treatment has saved millions of lives, TB is still the ninth leading cause of death worldwide and the leading cause from a single infectious agent.
 


Currently, there is only one vaccine against tuberculosis available worldwide: Bacille Calmette- Gutuberculosis. However, BCG has little to no efficacy in preventing pulmonary TB in adolecents and adults.



We are an international network of scientists and experts dedicated to fostering innovation and collaboration in the up-stream TB vaccine discovery and development space. Our goal is to accelerate discovery and development of a vaccine to prevent TB infection and disease in adolescents and adults.
​

We believe that early career scientists are essential to ensuring the field remains innovative and infusing new ways to tackle the scientific challenges in TB vaccine development. We recognize the efforts of early career scientists who have made significant contributions to research in TB host-pathogen biology, immunology, and vaccinology.
 

Adam Penn-Nicholson, Ph.D.
Joshua Mattila, Ph.D.
Javeed Shah, Ph.D.
Iman Satti, Ph.D.
University of Cape Town, South Africa University of Pittsburgh, US University of Washington, US The Jenner Institute, University of Oxford, UK